Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency
- PMID: 22291489
- PMCID: PMC3262370
- DOI: 10.2147/CPAA.S6475
Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency
Abstract
Adrenocortical insufficiency occurs when there is inadequate release of cortisol from the adrenal cortex. Disturbances of the hypothalamic-pituitary-adrenal axis are common following trauma, surgical stress, and critical illness. While this is often a protective mechanism, these responses may become "uncoupled" or maladaptive resulting in an exacerbation of organ failure and higher mortality rates. In these clinical settings, the patient presents with a persistent systemic inflammation state, a hyperdynamic cardiovascular response, and vasopressor dependent shock. As such, the occurrence of adrenal insufficiency in the setting of critical illness is most appropriately termed critical illness-related corticosteroid insufficiency. In these settings, recent data suggests that these patients may benefit from a short course of low-dose steroid replacement therapy. Cosyntropin, a synthetic derivative of adrenocorticotropic hormone, is being used with increased frequency in the evaluation and diagnosis of adrenocortical insufficiency in this patient population. A random cortisol level is checked before a 250-μg injection of cosyntropin and then 30-60 minutes later. The cortisol levels and response to cosyntropin may be interpreted to identify an insufficient adrenal response. Of note, the setting of critical illness can greatly affect the cosyntropin test sensitivity on identifying adrenal insufficiency. Changes in the stress response during critical illness combined with the resuscitation and management of these patients greatly disturbs serum protein levels, especially those of albumin and transcortin. Common intensive care unit (ICU) diagnoses such as sepsis and malnutrition can increase baseline levels and blunt the cortisol response to cosyntropin stimulation, respectively. As well, numerous pharmacological agents routinely used in the ICU have been shown to interfere with cortisol levels and cosyntropin responsiveness. While steroids have a place in the ICU, specific dosing and length of administration remain inconsistent.
Keywords: ACTH; adrenal insufficiency; cosyntropin; critical illness.
Similar articles
-
Diagnosis of adrenal insufficiency in severe sepsis and septic shock.Am J Respir Crit Care Med. 2006 Dec 15;174(12):1319-26. doi: 10.1164/rccm.200509-1369OC. Epub 2006 Sep 14. Am J Respir Crit Care Med. 2006. PMID: 16973979
-
A Case of Adrenal Insufficiency Diagnosed Using Optimal Dosing of Cosyntropin During Stimulation Testing.Am J Case Rep. 2021 Jan 23;22:e927533. doi: 10.12659/AJCR.927533. Am J Case Rep. 2021. PMID: 33483462 Free PMC article.
-
A high-sensitivity test in the assessment of adrenocortical insufficiency: 10 microg vs 250 microg cosyntropin dose assessment of adrenocortical insufficiency.J Endocrinol. 1998 Nov;159(2):275-80. doi: 10.1677/joe.0.1590275. J Endocrinol. 1998. PMID: 9795368
-
EVALUATION AND MANAGEMENT OF ADRENAL INSUFFICIENCY IN CRITICALLY ILL PATIENTS: DISEASE STATE REVIEW.Endocr Pract. 2017 Jun;23(6):716-725. doi: 10.4158/EP161720.RA. Epub 2017 Mar 23. Endocr Pract. 2017. PMID: 28332876 Review.
-
Can 1 microg of cosyntropin be used to evaluate adrenal insufficiency in critically ill patients?Ann Pharmacother. 2005 Apr;39(4):691-8. doi: 10.1345/aph.1E139. Epub 2005 Mar 1. Ann Pharmacother. 2005. PMID: 15741424 Review.
Cited by
-
Prevalence of Adrenal Insufficiency in Korean Patients undergoing Total Knee Arthroplasty.Ann Geriatr Med Res. 2024 Mar;28(1):20-26. doi: 10.4235/agmr.23.0123. Epub 2023 Nov 21. Ann Geriatr Med Res. 2024. PMID: 37984965 Free PMC article.
-
Harmonizing TUNEL with multiplexed iterative immunofluorescence enriches spatial contextualization of cell death.Cell Rep Methods. 2025 May 19;5(5):101047. doi: 10.1016/j.crmeth.2025.101047. Epub 2025 May 12. Cell Rep Methods. 2025. PMID: 40359937 Free PMC article.
-
Rapid hypothalamic-pituitary recovery after chronic glucocorticoid therapy enables strategies that prevent adrenal suppression.bioRxiv [Preprint]. 2025 May 4:2025.04.30.651350. doi: 10.1101/2025.04.30.651350. bioRxiv. 2025. PMID: 40655007 Free PMC article. Preprint.
-
Long-term corticosteroid use, adrenal insufficiency and the need for steroid-sparing treatment in adult severe asthma.J Intern Med. 2021 Aug;290(2):240-256. doi: 10.1111/joim.13273. Epub 2021 Apr 1. J Intern Med. 2021. PMID: 33598993 Free PMC article. Review.
-
Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?Orphanet J Rare Dis. 2021 Mar 4;16(1):117. doi: 10.1186/s13023-021-01758-9. Orphanet J Rare Dis. 2021. PMID: 33663533 Free PMC article. Review.
References
-
- Oelkers W, Diederich S, Bahr V. Diagnosis of adrenal cortex insufficiency. Dtsch Med Wochenschr. 1994;119(15):555–559. - PubMed
-
- Kong MF, Jeffcoate W. Eighty-six cases of Addison’s disease. Clin Endocrinol (Oxf) 1994;41(6):757–761. - PubMed
-
- Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335(16):1206–1212. - PubMed
-
- Topliss DJ, White EL, Stockigt JR. Significance of thyrotropin excess in untreated primary adrenal insufficiency. J Clin Endocrinol Metab. 1980;50(1):52–56. - PubMed
-
- Muls E, Bouillon R, Boelaert J, et al. Etiology of hypercalcemia in a patient with Addison’s disease. Calcif Tissue Int. 1982;34(6):523–526. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials